PREdiabetes GLycemic Impact and Data Evaluation

Recruiting N/A Interventional Study
Pre Diabetic Obesity & Overweight Insulin Resistance
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Study type
Interventional
Purpose
Prevention
Participants needed
80 (estimated)
Sponsor
Nazarii Kobyliak · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
This prospective, randomized controlled trial evaluates whether real-time continuous glucose monitoring (CGM) improves glycemic control and lifestyle adherence in adults with prediabetes compared to conventional self-monitoring methods over a 3-month period. By analyzing metabolic markers and behavioral data, the study aims to determine the effectiveness of 24-hour monitoring as a personalized too…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Age of 18 years and older. * Presence of prediabetes diagnosed according to criteria of the American Diabetes Association * Persons who treated with diet and exercise alone or metformin on a stabilized dose for at least 3 months before the study; * Ability to comply with proto…
Contacts

Nazarii Kobyliak, Professor

+380442356005

nazariikobyliak@gmail.com

CONTACT

Ilona Rudneva, Dr

0442356005

ilonarudneva57@gmail.com

CONTACT